
|Articles|March 22, 2007
Vasogen Names Terry H. Gregg President and CEO
Author(s)BioPharm International Editors
Vasogen, Inc. (Ontario, Canada, www.vasogen.com), has appointed Terrance H. Gregg to succeed David G. Elsley as president and CEO of Vasogen.
Advertisement
Vasogen, Inc. (Ontario, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
2
Novel Delivery Approaches of Biopharmaceuticals 2025
3
EMA Director Highlights Agency Achievements in 2025
4
FAQ: What Precision Analytics Have Done to Advance Next-Gen Biologics
5




